New clinical data confirm that safe, low-cost ketamine is not only effective but also well-tolerated…
Read More
A recent active-controlled trial using subcutaneous ketamine injections over four weeks has demonstrated strong efficacy…
A new large-scale trial conducted by researchers at the University of New South Wales (UNSW)…
A groundbreaking clinical trial published in the New England Journal of Medicine (NEJM) has reignited…
Major depressive disorder (MDD) continues to be a leading cause of disability worldwide, affecting over…
